Drugs / Gam-COVID-Vac Lyo
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04437875 | Jun → Aug 2020 | — | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gam-COVID-Vac Lyo | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04437875 ↗ |
| Modality | Vaccine | “adenoviral-based vaccine against SARS-CoV-2” NCT04437875 ↗ |
| Route | Intramuscular | “intramuscular administration” NCT04437875 ↗ |